News
|
AevisBio entered into a collaborative research with KRIBB
관리자 │ 2023-01-17 HIT 806 |
|---|
|
In July of 2019, AevisBio and Korea Research Institute of Bioscience & Biotechnology (KRIBB) announced a collaboration to discover, develop, and commercialize therapies for treating disease of aging, including Parkinson’s disease. |
| Previous Post | Bio Research Center founded at Bio Venture Center, KRIBB |
|---|---|
| Next Post | Korean Government grant (TIPS) awarded |
582 Daedeok-daero, Octo Building 601, Yuseong-gu, Daejeon, Republic of KoreaTel+82 70-4172-2900Fax+82 42-862-3781Mailinfo@aevisbio.com
COPYRIGHT(C) 2022 AEVISBIO, INC. ALL RIGHTS RESERVED.